New York State Suffolk County to Ban Sale of Disguised E-cigarette Products

Regulations by 2FIRSTS.ai
Nov.27.2023
New York State Suffolk County to Ban Sale of Disguised E-cigarette Products
A new law in Suffolk County, New York, aims to ban the sale of e-cigarette products disguised as school supplies.

According to Newsday, a bill in Suffolk County, New York, that would ban the sale of e-cigarette products disguised as school supplies and personal items will have a public hearing on December 5th.

 

The bill prohibits the sale of e-cigarette devices that resemble fluorescent pens, USB drives, ballpoint pens, phone cases, smartwatches, and backpacks.

 

The sponsor of the bill, state legislator Jim Mazzarella, stated that he hopes to ensure that the bill is in line with state laws, including the definition of smoking and the potential repercussions for businesses that violate the regulations and risk losing their licenses.

 

In August of this year, the Food and Drug Administration (FDA) sent warning letters to 15 online retailers for selling and/or distributing unauthorized e-cigarette products that are packaged to resemble cartoon characters, school supplies, toys, and beverages, appealing to teenagers. Selling e-cigarettes to individuals below the age of 21 is illegal.

 

The President of the New York Convenience Store Association, Kent Sopris, based in Albany, has expressed support for the bill, with the expectation that the county would commit to enforcing it. It is worth noting that online sales of e-cigarette products were prohibited in the state of New York in 2020. Recent data reveals that approximately one out of every ten American middle and high school students, equivalent to 2.55 million individuals, have used e-cigarettes at least once within 30 days of being surveyed in 2022.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
A joint operation by multiple departments in Brazil seized 20 boxes of illegal e-cigarettes worth about $90,000
A joint operation by multiple departments in Brazil seized 20 boxes of illegal e-cigarettes worth about $90,000
Brazilian federal police, border patrol, and military jointly seize 20 crates of illegal e-cigarettes in Altônia National Park.
Sep.18 by 2FIRSTS.ai
Singapore Teen Arrested for Selling Vapes, Products Sourced from Malaysia
Singapore Teen Arrested for Selling Vapes, Products Sourced from Malaysia
A 19-year-old woman in Singapore was arrested after advertising vape sales on the messaging app WhatsApp. On August 19, she pleaded guilty to two charges, including possession of an imitation tobacco product and advertising the sale of vapes online.
Aug.20 by 2FIRSTS.ai
British American Tobacco France: A complete ban on tobacco-free nicotine pouches could drive the expansion of the black market
British American Tobacco France: A complete ban on tobacco-free nicotine pouches could drive the expansion of the black market
British American Tobacco (BAT) France expressed opposition to the government's plan to ban tobacco-free nicotine pouches in the National Assembly, arguing that a ban would foster a vibrant black market and harm public health and the protection of minors. The company also cited the examples of Sweden and New Zealand, which have reduced smoking rates through "clear regulations and strict controls," and proposed three policy recommendations: ban sales to minors, strictly regulate smokeless nicotine
Sep.26 by 2FIRSTS.ai
UK MHRA Approved E-cigarette Products List Updated|Number of Approved SKUs Surges to 1,156, with cartridges Accounting for 1,033 (August 11–17)
UK MHRA Approved E-cigarette Products List Updated|Number of Approved SKUs Surges to 1,156, with cartridges Accounting for 1,033 (August 11–17)
Between August 11 and August 17, the UK Medicines and Healthcare products Regulatory Agency (MHRA) e-cigarette product notification database published 1,156 SKUs. These updates included rechargeable devices, refillable devices, device kits, and independent pods/components from brands such as ELFBAR, HQD, OXBAR, MOKI, HAYATI, and JNR.
Aug.19 by 2FIRSTS.ai
Altria Raises Dividend to $1.06; Annual Payout Ratio Rises to 78%
Altria Raises Dividend to $1.06; Annual Payout Ratio Rises to 78%
U.S. tobacco giant Altria Group, Inc. (NYSE: MO) announced a 3.9% increase to its quarterly dividend, lifting the payout to $1.06 per share and bringing the annualized dividend to $4.24. Investment bank Stifel on August 21 maintained its “Buy” rating and raised its price target from $65 to $72. Backed by strong free cash flow, Altria expects to maintain mid-single-digit dividend growth going forward.
Aug.29 by 2FIRSTS.ai